Prosecution Insights
Last updated: November 20, 2026

Robert A Zeman, USPTO Patent Examiner

Listed by the USPTO as ZEMAN, ROBERT A

Tech Center 1700 • Art Units: 1645 1792

This examiner grants 54% of resolved cases

Analysis

ZEMAN, ROBERT A works in Tech Center 1700 and Art Unit 1645. Across 794 resolved cases, the allowance rate is 54.4%, the interview lift is 27.7%, and the median time to allowance is 1340 days. The substantial case record supports a moderate allowance assessment, while the interview figure identifies a meaningful prosecution lever.

The listed companies are Arizona Board of Regents on Behalf of Arizona State University, The Board of Trustees of the University of Illinois, and Intervet Inc. The listed firms are QUARLES & BRADY LLP, MYERS BIGEL, P.A., and PA - BOZICEVIC FIELD & FRANCIS LLP. Practitioners should account for both the interview association and the extended median timing.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Performance Statistics

54.4%
Allow Rate
-10.6% vs TC avg
848
Total Applications
+27.7%
Interview Lift
1340
Avg Prosecution Days
Based on 794 resolved cases, 2023–2026

Rejection Statute Breakdown

6.2%
§101 Eligibility
16.6%
§102 Novelty
22.8%
§103 Obviousness
44.7%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
18872768 STAPHYLOCOCCUS AUREUS VACCINE Non-Final OA THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
18531938 METHOD TO PROVIDE LONG-LASTING CLEANING Final Rejection The Procter & Gamble Company
17750968 VACCINE AND METHODS FOR DETECTING AND PREVENTING FILARIASIS Non-Final OA THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS
17601051 MULTIVALENT VACCINES DERIVED FROM KLEBSIELLA OUTER MEMBRANE PROTEINS Non-Final OA University of Pittsburgh-Of the Commonwealth System of Higher Education
18270611 METHODS AND COMPOSITION FOR THE TREATMENT OF AUTISM SPECTRUM DISORDER Final Rejection The General Hospital Corporation
18826610 ENGINEERED BACTERIAL RIBOSOME COMPOSITIONS AND METHODS Non-Final OA ARIZONA BOARD OF REGENTS ON BEHALF OF ARIZONA STATE UNIVERSITY
18484980 STREPTOCOCCUS THERMOPHILUS STARTER STRAIN Final Rejection DSM IP Assets B.V.
17924064 Methods for Verification of Drug Levels Using Dried Blood Samples Non-Final OA Sanofi
18873753 VACCINE FOR PROTECTION AGAINST LEPTOSPIRA SEROVAR ICTEROHAEMORRHAGIAE Non-Final OA INTERVET INC.
17641031 COMBINATION VACCINE FOR INTRADERMAL ADMINISTRATION Final Rejection INTERVET INC.
16347861 DNA ANTIBODY CONSTRUCTS FOR USE AGAINST LYME DISEASE Non-Final OA THE WISTAR INSTITUTE OF ANATOMY AND BIOLOGY

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Who Appears Before This Examiner

Top companies before this examiner

Law firms appearing most often

Frequently Asked Questions

What is examiner Robert A Zeman's allowance rate?

54.4% of resolved applications examined by Robert A Zeman were allowed (794 resolved cases), compared with 49.4% across Art Unit 1645 over the last five years.

Does an interview help with examiner Robert A Zeman?

This examiner's interview lift is +27.7 percentage points: the difference in allowance rate between resolved applications that had an examiner interview and those that did not.

How long does examiner Robert A Zeman take to allow a patent?

Applications allowed by Robert A Zeman took 1,340 days on average from filing to allowance.

Which art unit does examiner Robert A Zeman work in?

Robert A Zeman examines applications in Art Unit 1645 in Tech Center 1700 (Chemistry & Materials).

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month